Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-279-4 | CAS number: 24468-28-8
Endpoint summary
Administrative data
Description of key information
No acute toxicity studies with zinc cyanurate are available, thus the acute toxicity will be addressed with existing data on the dissociation products zinc and cyanuric acid. The acute oral, dermal and inhalation toxicity for zinc cyanurate is above the limit dose of 2000mg/kg bw and the limit concentration of 5 mg/L, since both constituents have not shown any acute oral, dermal or inhalation toxicity up to the limit dose or concentration.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
No acute toxicity studies with zinc cyanurate are available, thus the acute toxicity will be addressed with existing data on the dissociation products zinc and cyanuric acid. Further details on the acute toxicity of the individual constituents within the framework of regulation (EC) 1907/2006 are given below.
The acute oral, dermal and inhalation toxicity for zinc cyanurate is above the limit dose of 2000mg/kg bw and 5 mg/L respectively, since both constituents have shown no sign of acute oral, dermal or inhalation toxicity. Hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute toxicity.
Further testing is not required. For further information on the toxicity of the individual constituents, please refer to the relevant sections in the IUCLID and CSR.
Justification for classification or non-classification
Zinc cyanurate does not require classification for acute oral toxicity, since the individual constituents have not shown any acute toxicity in the respective route-specific acute toxicity tests.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
